glp-1 gi obstruction lawsuit in kentucky Trulicity [2026] kentucky glp-1 gastrointestinal obstruction attorney

Liraglutide is a synthetic GLP-1 analog given as a once-daily injection

"Weve made this decision after careful consideration and to be responsive to customers whove expressed to us that they are no longer able to bear the burden of paying for these high-priced medications," the statement said

Diabetes care, 38(6), 10581066

You could argue that GLP-1 MoA is somewhat derisked so you are not looking at at 90% risk of not making it to market (not knowing anything of the specific target in question here)

doi: 10.1089/thy.2007.0381 35 GoddardAFSpillerRC

Meanwhile, no relationship between albiglutide and hypoglycemia was observed, as its ROR, PRR, and EBGM signals did not meet the criteria